As a Venture Partner at Starta Ventures Accelerator, he provided valuable consulting to health-tech enterprises and entrepreneurs, guiding them in start-up development and investment strategies. Additionally, as a Partner at Enso Ventures, Dr. Petukhov played a pivotal role in establishing the fund, generating crucial deal flow, leading due diligence processes, and strategically guiding portfolio companies to successful exits.
In earlier roles as an Associate at Rusnano Fund and a Scientific Advisor at Arnold & Porter Kaye Scholer LLP, Dr. Petukhov contributed to the establishment of biotechnology-focused investment departments, conducted comprehensive due diligence, and provided strategic advisory services to Big Pharma clients on their intellectual property (IP) matters.
Dr. Petukhov holds postdoctoral studies in Molecular Biology from The Rockefeller University and Population Council, Virology, and Biochemistry from the University of Edinburgh, as well as Biochemistry and Molecular Biology from the University of Cambridge. He also holds degrees in Biophysics and Doctor of Veterinary Medicine (DVM) from Moscow State Academy of Veterinary Medicine and Biotechnology.